IVAN ROSAS to Lung Diseases, Interstitial
This is a "connection" page, showing publications IVAN ROSAS has written about Lung Diseases, Interstitial.
Connection Strength
11.348
-
Pirfenidone in rheumatoid arthritis-associated interstitial lung disease - Authors' reply. Lancet Respir Med. 2023 06; 11(6):e52.
Score: 0.721
-
Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers. Am J Respir Crit Care Med. 2015 Jun 15; 191(12):1403-12.
Score: 0.420
-
Update in diffuse parenchymal lung disease, 2013. Am J Respir Crit Care Med. 2015 Feb 01; 191(3):270-4.
Score: 0.410
-
Functional impact of a spectrum of interstitial lung abnormalities in rheumatoid arthritis. Chest. 2014 Jul; 146(1):41-50.
Score: 0.393
-
Interstitial lung disease: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases. Ann Am Thorac Soc. 2014 Apr; 11 Suppl 3:S169-77.
Score: 0.386
-
A roadmap to promote clinical and translational research in rheumatoid arthritis-associated interstitial lung disease. Chest. 2014 Mar 01; 145(3):454-463.
Score: 0.384
-
The expanding role of biomarkers in the assessment of smoking-related parenchymal lung diseases. Chest. 2012 Oct; 142(4):1027-1034.
Score: 0.348
-
Subclinical interstitial lung disease: why you should care. Am J Respir Crit Care Med. 2012 Jun 01; 185(11):1147-53.
Score: 0.334
-
Automated quantification of high-resolution CT scan findings in individuals at risk for pulmonary fibrosis. Chest. 2011 Dec; 140(6):1590-1597.
Score: 0.317
-
Progressive preclinical interstitial lung disease in rheumatoid arthritis. Arch Intern Med. 2008 Jan 28; 168(2):159-66.
Score: 0.252
-
Early interstitial lung disease in familial pulmonary fibrosis. Am J Respir Crit Care Med. 2007 Oct 01; 176(7):698-705.
Score: 0.243
-
When it comes to genes--IPF or NSIP, familial or sporadic--they're all the same. Am J Respir Crit Care Med. 2007 Jan 01; 175(1):5-6.
Score: 0.234
-
Visual and Quantitative Interstitial Lung Abnormality Progression in COPDGene. Am J Respir Crit Care Med. 2025 Oct; 211(10):1794-1801.
Score: 0.214
-
Approach to the Evaluation and Management of Interstitial Lung Abnormalities: An Official American Thoracic Society Clinical Statement. Am J Respir Crit Care Med. 2025 Jul; 211(7):1132-1155.
Score: 0.211
-
Protein biomarkers of interstitial lung abnormalities in relatives of patients with pulmonary fibrosis. Eur Respir J. 2025 Jun; 65(6).
Score: 0.210
-
Early nintedanib deployment in COVID-19 interstitial lung disease (ENDCOV-I): study protocol of a randomised, double-blind, placebo-controlled trial. BMJ Open Respir Res. 2025 Apr 10; 12(1).
Score: 0.207
-
Development, Progression, and Mortality of Suspected Interstitial Lung Disease in COPDGene. Am J Respir Crit Care Med. 2024 Dec 15; 210(12):1453-1460.
Score: 0.203
-
Short peripheral blood leukocyte telomere length in rheumatoid arthritis-interstitial lung disease. Thorax. 2024 01 18; 79(2):182-185.
Score: 0.191
-
Tuftelin1 drives experimental pulmonary fibrosis progression by facilitating stress fiber assembly. Respir Res. 2023 Dec 17; 24(1):318.
Score: 0.189
-
Peptidylarginine deiminase 2 citrullinates MZB1 and promotes the secretion of IgM and IgA. Front Immunol. 2023; 14:1290585.
Score: 0.189
-
Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease. Rheumatology (Oxford). 2023 05 02; 62(5):1877-1886.
Score: 0.181
-
Interstitial Lung Disease in Veterans: Leveraging Big Data to Bridge Evidence and Practice Gaps. Ann Am Thorac Soc. 2023 04; 20(4):504-507.
Score: 0.180
-
Progressive Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis. Am J Respir Crit Care Med. 2023 01 15; 207(2):211-214.
Score: 0.178
-
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease. Respir Res. 2023 Jan 09; 24(1):6.
Score: 0.177
-
Suspected Interstitial Lung Disease in COPDGene Study. Am J Respir Crit Care Med. 2023 01 01; 207(1):60-68.
Score: 0.177
-
Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity. Intensive Care Med. 2022 12; 48(12):1803-1806.
Score: 0.173
-
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study. Lancet Respir Med. 2023 01; 11(1):87-96.
Score: 0.173
-
Interstitial lung abnormalities are associated with decreased mean telomere length. Eur Respir J. 2022 08; 60(2).
Score: 0.173
-
Screening for preclinical parenchymal lung disease in rheumatoid arthritis. Rheumatology (Oxford). 2022 08 03; 61(8):3234-3245.
Score: 0.172
-
Serum proteomic profiling of rheumatoid arthritis-interstitial lung disease with a comparison to idiopathic pulmonary fibrosis. Thorax. 2022 10; 77(10):1041-1044.
Score: 0.172
-
Detection and Early Referral of Patients With Interstitial Lung Abnormalities: An Expert Survey Initiative. Chest. 2022 02; 161(2):470-482.
Score: 0.160
-
Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases. Respir Res. 2021 Mar 16; 22(1):84.
Score: 0.156
-
Methotrexate and rheumatoid arthritis associated interstitial lung disease. Eur Respir J. 2021 02; 57(2).
Score: 0.155
-
Baseline Characteristics and Progression of a Spectrum of Interstitial Lung Abnormalities and Disease in Rheumatoid Arthritis. Chest. 2020 10; 158(4):1546-1554.
Score: 0.148
-
Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis. Am J Respir Crit Care Med. 2020 05 15; 201(10):1240-1248.
Score: 0.148
-
Comparative Profiling of Serum Protein Biomarkers in Rheumatoid Arthritis-Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis. Arthritis Rheumatol. 2020 03; 72(3):409-419.
Score: 0.145
-
Overlap of Genetic Risk between Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2019 12 01; 200(11):1402-1413.
Score: 0.143
-
The Design and Rationale of the Trail1 Trial: A Randomized Double-Blind Phase 2 Clinical Trial of Pirfenidone in Rheumatoid Arthritis-Associated Interstitial Lung Disease. Adv Ther. 2019 11; 36(11):3279-3287.
Score: 0.141
-
Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Prospective Cohort Study. Arthritis Rheumatol. 2019 09; 71(9):1472-1482.
Score: 0.140
-
Imaging Patterns Are Associated with Interstitial Lung Abnormality Progression and Mortality. Am J Respir Crit Care Med. 2019 07 15; 200(2):175-183.
Score: 0.139
-
Objectively Measured Chronic Lung Injury?on Chest CT. Chest. 2019 12; 156(6):1149-1159.
Score: 0.139
-
Increased Airway Wall Thickness in Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis. Ann Am Thorac Soc. 2019 04; 16(4):447-454.
Score: 0.137
-
MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease. N Engl J Med. 2018 12 06; 379(23):2209-2219.
Score: 0.132
-
Histopathology of Interstitial Lung Abnormalities in the Context of Lung Nodule Resections. Am J Respir Crit Care Med. 2018 04 01; 197(7):955-958.
Score: 0.127
-
Rituximab in the Treatment of Interstitial Lung Disease Associated with Antisynthetase Syndrome: A Multicenter Retrospective Case Review. J Rheumatol. 2018 06; 45(6):841-850.
Score: 0.127
-
The MUC5B promoter polymorphism is associated with specific interstitial lung abnormality subtypes. Eur Respir J. 2017 09; 50(3).
Score: 0.123
-
Clinical and Genetic Associations of Objectively Identified Interstitial Changes in?Smokers. Chest. 2017 10; 152(4):780-791.
Score: 0.120
-
Genetics and Idiopathic Interstitial Pneumonias. Semin Respir Crit Care Med. 2016 06; 37(3):321-30.
Score: 0.112
-
A comparison of visual and quantitative methods to identify interstitial lung abnormalities. BMC Pulm Med. 2015 Oct 29; 15:134.
Score: 0.108
-
Rheumatoid Arthritis-Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis: Shared Mechanistic and Phenotypic Traits Suggest Overlapping Disease Mechanisms. Rev Invest Clin. 2015 Sep-Oct; 67(5):280-6.
Score: 0.107
-
Short telomeres, telomeropathy, and subclinical extrapulmonary organ damage in patients with interstitial lung disease. Chest. 2015 Jun; 147(6):1549-1557.
Score: 0.105
-
Biomarkers of rheumatoid arthritis-associated interstitial lung disease. Arthritis Rheumatol. 2015 Jan; 67(1):28-38.
Score: 0.102
-
MUC5B promoter polymorphism and interstitial lung abnormalities. N Engl J Med. 2013 Jun 06; 368(23):2192-200.
Score: 0.091
-
Interstitial pneumonitis and the risk of chronic allograft rejection in lung transplant recipients. Chest. 2013 May; 143(5):1430-1435.
Score: 0.091
-
Identification of citrullinated hsp90 isoforms as novel autoantigens in rheumatoid arthritis-associated interstitial lung disease. Arthritis Rheum. 2013 Apr; 65(4):869-79.
Score: 0.090
-
Interstitial lung abnormalities and reduced exercise capacity. Am J Respir Crit Care Med. 2012 Apr 01; 185(7):756-62.
Score: 0.083
-
Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med. 2011 Mar 10; 364(10):897-906.
Score: 0.078
-
Identification of early interstitial lung disease in smokers from the COPDGene Study. Acad Radiol. 2010 Jan; 17(1):48-53.
Score: 0.071
-
Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease. Arthritis Rheum. 2009 Jul; 60(7):2183-92.
Score: 0.070
-
Proteomic Biomarkers of Quantitative Interstitial Abnormalities in COPDGene and CARDIA Lung Study. Am J Respir Crit Care Med. 2024 05 01; 209(9):1091-1100.
Score: 0.049